Literature DB >> 17882960

Sterol composition in field-grown and cultured mycelia of Inonotus obliquus.

Wei-fa Zheng1, Tong Liu, Xiao-yan Xiang, Qi Gu.   

Abstract

Sterols are one of the active classes of compounds in Inonotus obliquus for their effective therapy of many diseases. In field environment, this fungus accumulates large amount of sterols. In cultured mycelia, however, this class of compounds is less accumulated. For analyzing the factors responsible for differing sterol composition, the field-grown and cultured mycelia were extracted with 80% ethanol at room temperature and total sterols were prepared using silicon gel column chromatography followed by identification using either GC-MS or spectroscopic methods. For culturing Inonotus obliquus, the seed culture was grown either in basic medium consisting of glucose (2%), yeast extract (0.5%), KH2PO4 (0.01%), MgSO4.7H20 (0.05%) and distilled water at pH 6.5, or the basic medium supplemented with serial concentrations of AgNO3. The results indicated that field-grown mycelia contained lanosterol and inotodiol (comprised 45. 47% and 25. 36% of the total sterols, respectively) and other 10 sterols (comprising the remaining 30.17%) including ergosterol biosynthetic intermediates such as 24-methylene dihydrolanosterol, 4,4-dimethylfecosterol, 4-methyl fecosterol, fecosterol and episterol. Column chromatography also led to the isolation of lanosterol, Inotodiol, trametenolic acid, foscoparianol B and a new triterpenoid foscoparianol D in field-grown mycelia. In comparison, the cultured mycelia only contained three sterols with ergosterol as the predominant one (82.20%). Lanosterol only accounted for 3.68%. Supplementing Ag+ into the culture at 0.28 micromol x L(-1) greatly enhanced content of lanosterol (accounting for 56.81%) and decreased the content of ergosterol (18.5%) together with the presence of intermediates for ergosterol biosynthesis. These results suggested that the sterol composition in mycelia of the fungus can be diversified by supplementing substances inhibiting enzymatic process towards the synthesis of ergosterol. Harsh growth conditions in field environment (i.e. temperature variation, UV irradiation etc.) can delay the synthesis of ergosterol and hereby diversify the sterol composition in the mycelia of Inonotus obliquus.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17882960

Source DB:  PubMed          Journal:  Yao Xue Xue Bao        ISSN: 0513-4870


  5 in total

1.  An Antifungal Benzimidazole Derivative Inhibits Ergosterol Biosynthesis and Reveals Novel Sterols.

Authors:  Petra Keller; Christoph Müller; Isabel Engelhardt; Ekkehard Hiller; Karin Lemuth; Holger Eickhoff; Karl-Heinz Wiesmüller; Anke Burger-Kentischer; Franz Bracher; Steffen Rupp
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

2.  RNA-Seq de Novo Assembly and Differential Transcriptome Analysis of Chaga (Inonotus obliquus) Cultured with Different Betulin Sources and the Regulation of Genes Involved in Terpenoid Biosynthesis.

Authors:  Narimene Fradj; Karen Cristine Gonçalves Dos Santos; Nicolas de Montigny; Fatima Awwad; Yacine Boumghar; Hugo Germain; Isabel Desgagné-Penix
Journal:  Int J Mol Sci       Date:  2019-09-04       Impact factor: 5.923

Review 3.  Antiprotozoal and Antitumor Activity of Natural Polycyclic Endoperoxides: Origin, Structures and Biological Activity.

Authors:  Valery M Dembitsky; Ekaterina Ermolenko; Nick Savidov; Tatyana A Gloriozova; Vladimir V Poroikov
Journal:  Molecules       Date:  2021-01-28       Impact factor: 4.411

Review 4.  In Silico Prediction of Steroids and Triterpenoids as Potential Regulators of Lipid Metabolism.

Authors:  Valery M Dembitsky
Journal:  Mar Drugs       Date:  2021-11-22       Impact factor: 5.118

5.  Supercritical CO2 Extraction of Triterpenoids from Chaga Sterile Conk of Inonotus obliquus.

Authors:  Nghia Huynh; Gabriele Beltrame; Marko Tarvainen; Jukka-Pekka Suomela; Baoru Yang
Journal:  Molecules       Date:  2022-03-14       Impact factor: 4.411

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.